
Syntis Bio
Syntis Bio develops novel oral therapies with targeted drug delivery technology to enhance bioavailability.
- 7
- Private company
- Boston, MA, USUnited States
Syntis Bio, founded with the mission to revolutionize drug delivery, focuses on developing novel oral therapies that utilize advanced targeted delivery technology to enhance bioavailability. The company's core vision is to improve patient outcomes by creating more effective and efficient drug formulations. Their primary market focus is on late-stage preclinical development, aiming to address unmet medical needs through innovative therapeutic solutions.
Notable figures associated with Syntis Bio include experienced scientists and industry veterans who bring a wealth of knowledge in pharmaceutical development. The company has garnered attention from prominent investors in the biotech sector, underscoring its potential impact. Key achievements include significant advancements in their drug delivery technology, positioning Syntis Bio as a promising player in the field of targeted oral therapies. Their work has the potential to transform treatment paradigms and improve the efficacy of various medications.
Similar Companies

i2o Therapeutics
i2obio.com

Concept Matrix Solutions
Receptor Life Sciences
receptorlife.com
NovaDel Pharma

Intact Therapeutics

Forward Therapeutics
forward-tx.com

VeraMorph
veramorph.com

Intezyne Technologies
intezyne.com

Bond Biosciences
bond.bio

Extend Biosciences
extendbio.com

Rani Therapeutics Holdings
Ziran Biopharmaceutical

Toralgen
toralgen.com

AcousticaBio
acoustica.bio

Aurion Biotech
aurionbiotech.com

Novel Therapeutic Technologies
ntt-inc.com
SpringLeaf Therapeutics

Cytonus Therapeutics
cytonus.com

Lindy Biosciences
lindybio.com

InSitu Biologics
Quick Facts
Who are Syntis Bio's competitors?
Companies similar to Syntis Bio include i2o Therapeutics, Concept Matrix Solutions, Receptor Life Sciences and NovaDel Pharma.
When was Syntis Bio founded?
Syntis Bio was founded in 2022.
Where is Syntis Bio's headquarters located?
Syntis Bio's headquarters is located in Boston, MA, US.
When was Syntis Bio's last funding round?
Syntis Bio's most recent funding round was for $33M (USD) in July 2025.
How much disclosed funding has Syntis Bio raised?
As of Jul 1, 2025, Syntis Bio has disclosed funding of $48.4M (USD). Undisclosed round amounts are excluded.
How many employees does Syntis Bio have?
Syntis Bio has 7 employees as of Feb 5, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Model
- Revenue
- Customer
- Main Product
- Also Known As
- Syntis Bio, Inc.
- Headquarters
- 135 Morrissey Boulevard
- Suite 101A
- Boston, MA, 02125
- US
- SEC CIK
- 0001943061
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified